Cyclodextrin News Year in Review 2018
The CDNews blog was created in July and after a short period of trial it started in September. During this
Category: CD derivatives
Opinion leaders of CD society getting together in Budapest
In the recent two weeks, Cyclolab had the pleasure to welcome two prominent pioneers of cyclodextrin research, Prof. Loftsson from
Protecting groups: Strategies and Applications in Carbohyrate Chemistry
The new book edited by Prof. Sébastien Vidal (University of Lyon) contains 17 chapters on various strategies and applications including
Antibody-Targeted Cyclodextrin-Based Nanoparticles for siRNA Delivery
In the laboratory of C. M. O’Driscoll (University College Cork), an antibody targeted cyclodextrin-based siRNA delivery vector (CD.DSPE-PEGFab) was developed
NO-releasing cyclodextrins
Nitric oxide (NO) is a signaling molecule produced by almost all types of organisms ranging from bacteria to plants and
Mannose with anti-cancer effect
In a recently published Nature report it was investigated how tumor cells respond to different forms of sugar [1]. It
Self-decontaminating biocatalyst against nerve gases
Chemical warfare agents (CWA) are one of the most brutal weapons created by mankind [1]. CWAs are inexpensive and are
Biodegradable antibacterial multilayer on polylactic acid-based food packaging
Polylactic acid (PLLA) was internally blended with zinc oxide nanoparticles and chitosan and carboxyethyl BCD (CEBCD) layers were deposited by
Special Issue of the journal Materials “Cyclodextrin-Based Nanomaterials: Synthesis, Properties, and Applications”
Cyclodextrins (CDs) have become a very common building-block for the design of new smart materials of different nature. This is
Antibody conjugated cyclodextrin for tumor drug delivery
Abzena company developed a series of antibody drug conjugates (ADCs) using IgG1, IgG2, IgG4, mAbs, and other antibodies modified with